Skip to main content
Erschienen in: Rheumatology International 4/2003

01.07.2003 | Case Report

Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency

verfasst von: Tomohiro Nakayama, Tatsuo Yamamoto, Katsuo Kanmatsuse, Shinichiro Kokubun

Erschienen in: Rheumatology International | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Abstract

A 33-year-old woman had experienced recurrent pregnancy loss. She had positive anticardiolipin antibody and protein S deficiency. Her pregnancy was managed with anticoagulant therapy and she delivered a healthy infant. Three years after delivery, she reported progressive sweating, tremor, tachycardia, and a 4-kg weight loss. She was diagnosed with Graves' disease. This is a rare case of combined anticardiolipin antibody positivity, acquired protein S deficiency, and Graves' disease.
Literatur
1.
Zurück zum Zitat Marongiu F, Conti M, Murtas ML, Sorano GG, Mameli G, Salis G, Mathieu A, Martino E. (1991) Anticardiolipin antibodies in Graves' disease: relationship with thrombin activity in vivo. Thromb Res 64:745–749PubMed Marongiu F, Conti M, Murtas ML, Sorano GG, Mameli G, Salis G, Mathieu A, Martino E. (1991) Anticardiolipin antibodies in Graves' disease: relationship with thrombin activity in vivo. Thromb Res 64:745–749PubMed
2.
Zurück zum Zitat Mayaudon H, Crozes P, Riveline JP, Boyer B, Simon P, Bauduceau B (1994) Anticorps antiphospholipides au cours d'une maladie de Basedow. Presse Med 23:1496 Mayaudon H, Crozes P, Riveline JP, Boyer B, Simon P, Bauduceau B (1994) Anticorps antiphospholipides au cours d'une maladie de Basedow. Presse Med 23:1496
3.
Zurück zum Zitat Hofbauer CL, Spitzweg C, Heufelder AE (1996) Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 23:1435–1437PubMed Hofbauer CL, Spitzweg C, Heufelder AE (1996) Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 23:1435–1437PubMed
4.
Zurück zum Zitat Forastiero RR, Kordich L, Basilotta E, Carreras LO (1994) Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 5:609–616PubMed Forastiero RR, Kordich L, Basilotta E, Carreras LO (1994) Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 5:609–616PubMed
5.
Zurück zum Zitat Fujii T (2002) Herbal factors in the treatment of autoimmunity-related habitual abortion. Vitam Horm 65:333–344PubMed Fujii T (2002) Herbal factors in the treatment of autoimmunity-related habitual abortion. Vitam Horm 65:333–344PubMed
6.
Zurück zum Zitat Fujii T, Kanai T, Kozuma S, Hamai Y, Hyodo H, Yamashita T, Miki A, Unno N, Taketani Y (2000) Theoretical basis for herbal medicines, Tokishakuyaku-san and Sairei-to, in the treatment of autoimmunity-related recurrent abortion by correcting T helper-1/T helper-2 balance. Am J Reprod Immunol 44:342–346PubMed Fujii T, Kanai T, Kozuma S, Hamai Y, Hyodo H, Yamashita T, Miki A, Unno N, Taketani Y (2000) Theoretical basis for herbal medicines, Tokishakuyaku-san and Sairei-to, in the treatment of autoimmunity-related recurrent abortion by correcting T helper-1/T helper-2 balance. Am J Reprod Immunol 44:342–346PubMed
7.
Zurück zum Zitat Fujii O, Kanai T, Kouzuma S, Baba K, Miki A, Hyodo H, Yamashita T, Unno N, Taketani Y. (2001) Herbal medicines, Sairei-to and Tokishakuyaku-san, differently modulate the release of cytokines from decidual versus peripheral blood mononuclear cells. Am J Reprod Immunol 46:369–372PubMed Fujii O, Kanai T, Kouzuma S, Baba K, Miki A, Hyodo H, Yamashita T, Unno N, Taketani Y. (2001) Herbal medicines, Sairei-to and Tokishakuyaku-san, differently modulate the release of cytokines from decidual versus peripheral blood mononuclear cells. Am J Reprod Immunol 46:369–372PubMed
8.
Zurück zum Zitat McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: B2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120–4124PubMed McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: B2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120–4124PubMed
9.
Zurück zum Zitat Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T (1994) Anticardiolipin antibodies recognize B2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179:457–462PubMed Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T (1994) Anticardiolipin antibodies recognize B2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179:457–462PubMed
10.
Zurück zum Zitat Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M (1996) Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol 134:97–103PubMed Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M (1996) Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol 134:97–103PubMed
11.
Zurück zum Zitat Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA (2001) Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31–35PubMed Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA (2001) Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31–35PubMed
12.
Zurück zum Zitat Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ (2000) Primary role of the HLA class II DRB1*0301 allele in Graves' disease. Am J Med Genet 95:432–437CrossRefPubMed Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ (2000) Primary role of the HLA class II DRB1*0301 allele in Graves' disease. Am J Med Genet 95:432–437CrossRefPubMed
13.
Zurück zum Zitat Ioannidis JP, Tektonidou MG, Vlachoyiannopoulos PG, Stavropoulos-Giokas C, Spyropoulou-Vlachou M, Reveille JD, Arnett FC, Moutsopoulos HM (1999) HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. Hum Immunol 60:1274–1280CrossRefPubMed Ioannidis JP, Tektonidou MG, Vlachoyiannopoulos PG, Stavropoulos-Giokas C, Spyropoulou-Vlachou M, Reveille JD, Arnett FC, Moutsopoulos HM (1999) HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. Hum Immunol 60:1274–1280CrossRefPubMed
14.
Zurück zum Zitat Arnett FC, Thiagarajan P, Ahn C, Reveille JD (1999) Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum 42:268–274CrossRefPubMed Arnett FC, Thiagarajan P, Ahn C, Reveille JD (1999) Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum 42:268–274CrossRefPubMed
15.
Zurück zum Zitat Christiansen OB, Ulcova-Gallova Z, Mohapeloa H, Krauz V (1998) Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages. Hum Reprod 13:3326–3331CrossRefPubMed Christiansen OB, Ulcova-Gallova Z, Mohapeloa H, Krauz V (1998) Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages. Hum Reprod 13:3326–3331CrossRefPubMed
16.
Zurück zum Zitat Forastiero RR, Kordich L, Basilotta E, Carreras LO (1994) Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 5:609–616PubMed Forastiero RR, Kordich L, Basilotta E, Carreras LO (1994) Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 5:609–616PubMed
17.
Zurück zum Zitat Merrill JT, Zhang HW, Shen C, Butman BT, Jeffries EP, Lahita RG, Myones BL (1999) Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. Thromb Haemost 81:748–757PubMed Merrill JT, Zhang HW, Shen C, Butman BT, Jeffries EP, Lahita RG, Myones BL (1999) Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. Thromb Haemost 81:748–757PubMed
18.
Zurück zum Zitat Paternoster DM, Simioni P, Girolami A (1997) Protein S deficiency and pregnancy: is there a case for ylaxis? Minerva Ginecol 49:447–448PubMed Paternoster DM, Simioni P, Girolami A (1997) Protein S deficiency and pregnancy: is there a case for ylaxis? Minerva Ginecol 49:447–448PubMed
Metadaten
Titel
Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency
verfasst von
Tomohiro Nakayama
Tatsuo Yamamoto
Katsuo Kanmatsuse
Shinichiro Kokubun
Publikationsdatum
01.07.2003
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 4/2003
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0291-6

Weitere Artikel der Ausgabe 4/2003

Rheumatology International 4/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.